These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 21864851)

  • 1. Evaluation of apoptosis-related genes: Fas (CD94), FasL (CD178) and TRAIL polymorphisms in Iranian multiple sclerosis patients.
    Mohammadzadeh A; Pourfathollah AA; Sahraian MA; Behmanesh M; Daneshmandi S; Moeinfar Z; Heidari M
    J Neurol Sci; 2012 Jan; 312(1-2):166-9. PubMed ID: 21864851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of apoptosis-related gene Fas (CD95) and FasL (CD178) polymorphisms in Iranian rheumatoid arthritis patients.
    Mohammadzadeh A; Pourfathollah AA; Tahoori MT; Daneshmandi S; Langroudi L; Akhlaghi M
    Rheumatol Int; 2012 Sep; 32(9):2833-6. PubMed ID: 21879377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymorphisms in the apoptosis-associated genes FAS and FASL and risk of oral cancer and malignant potential of oral premalignant lesions in a Taiwanese population.
    Wang LH; Ting SC; Chen CH; Tsai CC; Lung O; Liu TC; Lee CW; Wang YY; Tsai CL; Lin YC
    J Oral Pathol Med; 2010 Feb; 39(2):155-61. PubMed ID: 20359312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymorphisms of death pathway genes FAS and FASL and risk of premalignant gastric lesions.
    Hsu PI; Lu PJ; Wang EM; Ger LP; Lo GH; Tsay FW; Chen TA; Yang HB; Chen HC; Lin WS; Lai KH
    Anticancer Res; 2008; 28(1A):97-103. PubMed ID: 18383830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Putative association of Fas and FasL gene polymorphisms with clinical outcomes of hepatitis B virus infection.
    Jung YJ; Kim YJ; Kim LH; Lee SO; Park BL; Shin HD; Lee HS
    Intervirology; 2007; 50(5):369-76. PubMed ID: 17938571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphisms in promoter region of FAS and FASL gene and risk of cardia gastric adenocarcinoma.
    Zhou RM; Wang N; Chen ZF; Duan YN; Sun DL; Li Y
    J Gastroenterol Hepatol; 2010 Mar; 25(3):555-61. PubMed ID: 20074157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of FAS-670A/G and FASL-844C/T polymorphisms with idiopathic azoospermia in Western Iran.
    Asgari R; Mansouri K; Bakhtiari M; Bidmeshkipour A; Yari K; Shaveisi-Zadeh F; Vaisi-Raygani A
    Eur J Obstet Gynecol Reprod Biol; 2017 Nov; 218():55-59. PubMed ID: 28942044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of genes encoding apoptosis regulatory factors (FAS, FASL, TRAIL, BCL2, TNFR1 and TNFR2) in the pathogenesis of autoimmune thyroid diseases.
    Inoue N; Watanabe M; Ishido N; Kodu A; Maruoka H; Katsumata Y; Hidaka Y; Iwatani Y
    Hum Immunol; 2016 Oct; 77(10):944-951. PubMed ID: 27458112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional polymorphisms in FAS and FASL contribute to increased apoptosis of tumor infiltration lymphocytes and risk of breast cancer.
    Zhang B; Sun T; Xue L; Han X; Zhang B; Lu N; Shi Y; Tan W; Zhou Y; Zhao D; Zhang X; Guo Y; Lin D
    Carcinogenesis; 2007 May; 28(5):1067-73. PubMed ID: 17183065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study of Fas (CD95) and FasL (CD178) polymorphisms in liver transplant recipients.
    Marín LA; Muro M; Moya-Quiles MR; Miras M; Minguela A; Bermejo J; Sanchez-Bueno F; Parrilla P; Alvarez-López MR
    Tissue Antigens; 2006 Feb; 67(2):117-26. PubMed ID: 16441482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PAI and TPA gene polymorphisms in multiple sclerosis.
    Lovrecic L; Ristić S; Starcević-Cizmarević N; Brajenović-Milić B; Jazbec SS; Sepcić J; Kapović M; Peterlin B
    Mult Scler; 2008 Mar; 14(2):243-7. PubMed ID: 17986506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fas/FasL promoter gene polymorphism in patients with rheumatoid arthritis.
    Kobak Ş; Berdeli A
    Reumatismo; 2012 Dec; 64(6):374-9. PubMed ID: 23285481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional genetic variants in apoptosis-associated FAS and FASL genes and risk of bladder cancer in a Turkish population.
    Verim L; Timirci-Kahraman O; Akbulut H; Akbas A; Ozturk T; Turan S; Yaylim I; Ergen A; Ozturk O; Isbir T
    In Vivo; 2014; 28(3):397-402. PubMed ID: 24815844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A study of promoter and intronic markers of ApoI/Fas gene and the interaction with Fas ligand in relapsing multiple sclerosis.
    Lucas M; Zayas MD; De Costa AF; Solano F; Chadli A; Dinca L; Izquierdo G
    Eur Neurol; 2004; 52(1):12-7. PubMed ID: 15218339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymorphisms of death pathway genes FAS and FASL and risk of nasopharyngeal carcinoma.
    Cao Y; Miao XP; Huang MY; Deng L; Lin DX; Zeng YX; Shao JY
    Mol Carcinog; 2010 Nov; 49(11):944-50. PubMed ID: 20842669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymorphisms in the FAS and FASL genes and survival of early stage non-small cell lung cancer.
    Park JY; Lee WK; Jung DK; Choi JE; Park TI; Lee EB; Cho S; Park JY; Cha SI; Kim CH; Kam S; Jung TH; Jheon S
    Clin Cancer Res; 2009 Mar; 15(5):1794-800. PubMed ID: 19240174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of death pathway genes FAS and FASL polymorphisms in chronic HBV infection.
    Zamani AG; Barlas IO; Durakbasi-Dursun G; Ural O; Erdal E; Yildirim MS
    Int J Immunogenet; 2013 Dec; 40(6):482-7. PubMed ID: 23560484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional polymorphisms in FAS/FASL system contribute to the risk of occurrence but not progression of gastric cardiac adenocarcinoma.
    Zhang W; Li C; Wang J; He C
    Hepatogastroenterology; 2012; 59(113):141-6. PubMed ID: 21940365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional variants in cell death pathway genes and risk of pancreatic cancer.
    Yang M; Sun T; Wang L; Yu D; Zhang X; Miao X; Liu J; Zhao D; Li H; Tan W; Lin D
    Clin Cancer Res; 2008 May; 14(10):3230-6. PubMed ID: 18483392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The -670G>A polymorphism in the FAS gene promoter region influences the susceptibility to systemic sclerosis.
    Liakouli V; Manetti M; Pacini A; Tolusso B; Fatini C; Toscano A; Cipriani P; Guiducci S; Bazzichi L; Codullo V; Ruocco L; Dell'orso L; Carubbi F; Marrelli A; Abbate R; Bombardieri S; Ferraccioli G; Montecucco C; Valentini G; Matucci-Cerinic M; Ibba-Manneschi L; Giacomelli R
    Ann Rheum Dis; 2009 Apr; 68(4):584-90. PubMed ID: 18445624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.